# Innospec Inc. (IOSP) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Basic Materials / Chemicals. Price $93.95, market value $2.3 billion.

## Valuation
- **P/E (trailing): 19.2×** (5-yr avg 30.6×, 3-yr avg 37.4×). Innospec Inc. trades at 19.2× trailing earnings, well below its own five-year average of 30.6×: cheap by its own standards. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 15.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.3×**. Each dollar of revenue is priced at 1.3×.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 11.9×**. Enterprise value is 11.9× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Earnings yield: 5.2%**. The inverse of the P/E: 5.2% of the price is earned each year.

## Profitability
- **Gross margin: 27.5%**. Innospec Inc. keeps 27.5% of revenue after the direct cost of what it sells.
- **Operating margin: 7.0%**. 7.0% of revenue is left after running the business.
- **Net margin: 6.6%**. 6.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 8.8%**. 8.8% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 9.9%**. Return on all capital, debt included, is 9.9%.
- **Return on assets: 6.6%**. Each dollar of assets produces 6.6% of profit.

## Growth
- **Revenue growth (1 yr): -3.7%** (3-yr -3.3%/yr, 5-yr 8.3%/yr). Revenue fell 3.7% over the last year, against 8.3% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 228.9%** (3-yr -4.3%/yr, 5-yr 32.1%/yr). Earnings per share rose 228.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Innospec Inc. holds more cash than debt.
- **Current ratio: 2.79** (quick 2.79). Current assets cover the next year's liabilities 2.79 times.
- **Altman Z-score: 5.42**. A Z-score of 5.42 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 1.91%** ($1.79 per share, trailing). Innospec Inc. yields 1.91%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 36%**. 36% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 12**. 12 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 10.5%/yr** (1-yr 10.3%). The dividend has compounded at 10.5% a year over five years, doubling roughly every 7 years at that pace.

## Price and momentum
- **Total return (1 yr): 12.1%** (YTD 24.2%, 3-mo 16.4%). The shares are up 12.1% over twelve months including dividends.
- **From 52-week high: -2.8%** (43.4% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 59**. An RSI of 59 is neutral.
- **Beta (1 yr): 0.53** (volatility 24%). Beta of 0.53 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=IOSP · Page: https://foliofundamentals.com/stocks/iosp

Not investment advice.